Autorzy
Tytuł pracy
Czasopismo
Kategoria
IF 2020
MNiSW 2021
1.
Sharman J.P., Egyed M., Jurczak W., Skarbnik A., Pagel J.M., Flinn I.W.,
Kamdar M., Munir T., Walewska R., Corbett G., Fogliatto L.M., Herishanu Y., Banerji V., Coutre S., Follows G.,
Walker P., Karlsson K., Ghia P.,
Janssens A., Cymbalista F., Woyach J.A., Ferrant E., Wierda W.G.,
Munugalavadla V., Yu T., Wang M.H., Byrd J.C.
Longitudinal Health-Related Quality of Life Study among Cervical Cancer Patients Treated with RadEfficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without Obinutuzumab versus Obinutuzumab plus chlorambucil in treatment-naīve chronic lymphocytic leukemiaiotherapy
Leukemia, published online: 01 January 2022
DOI: 10.1038/s41375-021-01485-x
E
11,528
200
2.
Piechocki M., Koziołek W., Sroka D., Matrejek A., Miziołek P., Saluk N.,
Sledzik M., Jaworska A., Bereeza K.,
Pluta E., Banas T. (Ak)
Trends in Incidence and Mortality of Gynecological and Breast Cancer in Poland (1980-2018)
Clinical Epidemiology 2022, 14: 95-114
DOI: 10.2147/CLEP.S330081
A
4,79
140
3.
Puskulluoglu M., Tomaszewski K.A., Grela-Wojewoda A., Pacholczak-
Madej R., Ebner F.
Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients:
A Systemic Review
Medicine 2022, 58, 284: 1-14
DOI: 10.3390/medicina58020284
A
1,889
70
4.
Grela-Wojewoda A., Pacholczak-
Madej R., Adamczyk A., Korman M., Puskulluoglu M.
Cardiotoxicity induced by protein kinase inhibitors in patients with cancer
International Journal of Molecular Sciences 2022, 23, 2815
DOI:10.3390/ijms23052815
D
5,923
140
5.
Garbacz M., Gajewski J., Durante M., Kisielewicz K., Krah N., Kopeć R.,
Olko P., Patera V., Rinaldi I., Rydygier M., Schiavi A., Scifoni E., Skóra T.,
Skrzypek A., Tommasino F., Ruciński A
Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre
Radiation Oncology 2022
DOI: 10.1186/s13014-022-02022-5
A
3,481
100
6.
Rutkowski P., Wysocki P.J., Kozak K., Nasierowska-Gutmajer A., Jeziorski A., Wysocki W.M., Kalinka E., Świtaj T., Kamińska-Winciorek G., Czarnecka A.M., Kosela-Paterczyk H., Cybulska-Stopa B., Wisniewski P., Szumera-Cieckiewicz A., Zdzienicki M., Ziobro M., Fijuth J., Kawecki A., Tysarowski A., Romanowska-Dixon B., Markiewicz A., Dedecjus M., Kubiatowski T., Dolecki K., Tchórzewska-Korba H., Rudnicka L., Owczarek W., Krzakowski M.
Postępowanie diagnostyczno-terapeutyczne u chorych na czerniaki – zalecenia ekspertów
Expert recommendations on diagnostic-therapeutic management of melanoma patients
Onkologia w Praktyce Klinicznej – Edukacja
ISBN 978-83-67091-67-1
Via Medica
F
7.
Dudzisz-Śledź M., Sobczuk P., Kozak K., Świtaj T., Koseła-Paterczyk H.,
Czarnecka A.M., Falkowski S., Rogala P., Morysinski T., Spałek M.J., Zdzienicki M., Goryn T., Zietek M., Cybulska-Stopa B., Kłęk S., Kaminska-Winciorek G., Ziółkowska B., Szumera-Ciećkiewicz A., Rutkowski P.
Treatment of Locally Advanced Merkel Cell Carcinoma – A Multi-Center Study
Cancers 2022, 14: 422
DOI:10.3390/cancers14020422
A
6,639
140
8.
Pacholczak-Madej R., Grela-
Wojewoda A., Lompart J., Żuchowska-Vogegesang B., Ziobro M.
Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy
Prague Medical Report 2022, vol. 123, 1: 35-42
DOI:10.14712/23362936.2022.4
C
20
9.
Grela-Wojewoda A. (Ak), Niemiec J., Sas-Korczynska B., Zemełka T.,
Puskulluoglu M., Wysocki W.M., Wojewoda T., Pacholczak-Madej R., Adamczyk A., Mucha-Małecka A.,
Ziobro M., Konduracka E.
Adjuvant combined therapy with trastuzumab in patients with HER2-positive breast cancer and cardiac alterations: implications for optimal cardio-oncology care
Polish Archives of Internal Medicine 2022,132 (4):16204
DOI: 10.20452/pamw.16204
A
3,277
100
10.
Kaminska-Winciorek G., Słowinska M., Krotowski J., Nasierowska-Guttmajer A., Musiał J., Cybulska-Stopa B.
Dermoscopy of external ear melanoma (EEM)
Archives of Dermatological Research 2022, published online 17.03.2022
DOI: 10.1007/s00403-022-02342-2
C
3,017
70
11.
Cybulska-Stopa B., Kaminska-
Winciorek G., Rutkowski P.
Diagnostyka obrazowa
w obserwacji chorych na czerniaki skóry i błon śluzowych
Diagnostic imaging modalities for the surveillance of melanoma patients
Forum Dermatologicum 2022, 8(1): 30-35
DOI: 10.5603/FD.2022.0011
D
40
12.
Kaminska-Winciorek G., Cybulska-
Stopa B., Słowinska M.
Nowoczesne trendy dermaskopowe
w onkologii.
Modern dermoscopic trends in oncology
Forum Dermatologicum 2022, 8(1): 3-10
DOI: 10.5603/FD.2022.0009
D
40
13.
Tam C.S., Dimopoulos M., Garcia-Sanz R., Trotman J., Opat S., Roberts A.W.,
Owen R., Song Y., Xu W., Zhu J., Li J.,
Qiu L., D’Sa S., Jurczak W., Cull G., Marlton P., Gottlieb D., Munoz J.,
Philips T., Du Ch., Ji M., Zhou L., Guo H., Zhu H., Chan W.Y., Cohen A., Novotny W., Huang J., Tedeschi A.
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
Blood Advances 2022, 6, 4: 12961308
DOI:10.1182/bloodadvances.2021005621
D
6,686
40
14.
Kwak L.W., Sancho J.M., Cho S.G., Nakazawa H., Suzumiya J., Tumyan G., Kim J.S., Menne T., Mariz J., Ilyin N., Jurczak W., Martinez A.L., Samoilova O., Zhavrid E., Ruiz E.Y., Trneny M., Popplewell L., Ogura M., Kim W.S.,
Lee S.J., Kim S.H., Ahn K.Y., Buske Ch.
Efficacy and safety of CT-P10 versus rituximab in untreated low-tumor-burden follicular lymphoma: final results of a randomized phase III study
Clinical Lymphoma, Myeloma and Leukemia 2022: 89-97
DOI: 10.1016/j.clml.2021.08.005
A
3,231
70
15.
Kenig J., Szabat K., Mituś J., Rogula T., Krzeszowiak J.
Short = and long-term predictive power of the preoperative Geriatric Assessment components in older cancer patients undergoing high-risk abdominal surgery
European Journal of Surgical Oncology 2022
A
4.424
100
16.
Pula B., Pruszczyk K., Pietrusza E., Morawska M., Piszczek W., Kalicinska E., Szeremet A., Tryc-Szponder J., Wąsik-Szczepanek E., Drozd-Sokołowska J., Krzemień H., Rejus A., Gajewska M., Wiśniewski K., Wysocki M.,
Majeranowski A., Paszkiewicz-Kozik E., Steckiewicz P., Szukalski Ł., Bołkun Ł., Długosz-Danecka M., Giannopoulos K., Jamroziak K., Lech-Marańda E., Hus I.
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Cancers 2022, 14: 508
DOI: 10.3390/cancers14030558
A
6,639
140
17.
Borcinova M., Ragosch V., Jarkovsky J., Bajsova S., Pilka R., Glickman R., Garrido-Mallach S., Raspagliesi F., Szatkowski W., Pakiz M., Snyman L..C., Kocian R. Tamussino K., Kalist V., Michal M., Garcia Segovia M., Poka R., Kipp B, Szewczyk G., Wydra D., Toth R., Vinnytska A., Fischerova D., Siegler K., Cibula D.
Challenges in lower limb lymphodema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study
Gynecologic Oncology 164 (2022): 76-84
DOI: 10.1016/j.ygyno.2021.10.089
A
5,482
140
18.
Tambas M. van der Laan H.P.,
Steenbakkers R.J.H.M., Doyen J., Timmermann B., Orlandi E., Hoyer M., Haustermans K., Georg P., Burnet N.G., Gregoire V., Calugaru V., Troost E.G.C., Hoebers F., Calvo F.A., Widder J.,
Eberle F., van Vulpen M., Maingon P., Skóra T., Weber D.C., Bergfeldt K.,
Kubes J., Langendijk J.A.
Current practice in proton therapy delivery in adult cancer patients across Europe
Radiotherapy and Oncology167 (2022): 7-13
DOI: 10.1016/j.radonc.2021.12.004
A
6.280
140
19.
Vergote I., Gonzales-Martin A., Ray-Coquard I., Harter P., Colombo N., Pujol P., Lorusso D., Mirza M.R., Brasiuniene B., Madry R., Brenton J.D., Ausems M.G.E.M., Buttner R., Lambrechts D., on behalf of the European experts consensus group, w tym Blecharz P.
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
Annals of Oncology 2022, 33, 3:276-287
DOI:10.1016/j.annonc.2021.11.013
D
32,976
200
20.
Słowińska M., Dudzisz-Śledź M.,
Sobczuk P., Łasińska I., Pietruszka A., Cybulska-Stopa B., Kowalczyk A.,
Świtaj T., Czarnecka I., Koseła-
Paterczyk H., Rogala P., Paluchowska E., Składowski K., Mackiewicz J.,
Rutkowski P., Owczarek W.
Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
Journal of the European Academy of Dermatology and Venerology 2022 JEADV
DOI: 10.1111/jdv.18070
A
6,166
140
21.
Filipowicz N., Drążek K., Horbacz M., Wojdak A., Szymanowski J., Rychlicka-Buniowska E., Juhas U., Duzowska K., Nowikiewicz T., Stańkowska W., Chojnowska K., Andreou M.,
Ławrynowicz U., Wójcik M., Davies H., Śrutek E., Bieńkowski M., Milian-Ciesielska K., Zdrenka M., Ambicka A., Przewożnik M., Harazin_lechowska A., Adamczyk A., Kowalski J., Bała D., Wisniewski D., Tkaczyński K., Kamecki K., Drzewiecka M., Wroński P., Siekiera J., Ratnicka I., Jankau J., Wierzba K., Skokowski J., Połom K., Przydacz M., Bełch Ł., Chłosta P., Matuszewski M.,
Okoń K., Rostkowska O., Hellmann A., Sasin K., Remiszewski P., Sierżęga M.,
Hać S., Kobiela J., Kaska Ł., Jankowski M., Hodorowicz-Zaniewska D., Jaszczyński J., Zegarski W., Makarewicz W., Pękas R., Szpor J., Ryś J., Szylberg Ł., Piotrowski A., Dumański J.P.
Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition
Plos One 2022, April: 7
DOI:10.1371/journal.pone.0266111
A
3,240
100
22.
Pacholczak-Madej R., Grela-
Wojewoda A., Lompart J., Żuchowska-Vogelgesang B., Ziobro M. (Ak)
Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy
Prague Medical Report 2022, 123, 1: 35-42
DOI: 10.14712/23362936.2022.4
C
20
23.
Rogala P., Czarnecka A.M., Cybulska-Stopa B., Ostaszewski K., Piejko K.,
Ziętek M., Dziura R., Rutkowska E.,
Galus Ł., Kempa-Kamińska N., Calik J., Sałek-Zań A., Zemełka T., Bal W., Kamycka A., Świtaj T., Kamińska-Winciorek G., Suwiński R., Mackiewicz J., Rutkowski P.
Long-Term Outcomes of targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients – Real-World Evidence
Journal of Clinical Medicine 2022, 11: 2239
DOI: 10.3390/jcm11082239
A
4,241
140
24.
Ziółkowska B., Cybulska-Stopa B., Papntoniou D., Suwiński R.
Systemic treatment in patients with malignant pleural mesothelioma – real life experience
BMC Cancer 22, 22: 432
DOI: 10.1186/s12885-022-09490-8
A
4,430
100
25.
Rogala P., Czarnecka A.M., Cybulska-Stopa B., Ostaszewski K., Piejko K.,
Zietek M., Dziura R., Rutkowska E.,
Galus Ł., Kempa-Kamińska N.,
Seredyńska J., Bal W., Kozak K., Surus-Hyla A., Kubiatowski T., Kaminska-Winciorek G., Suwiński R., Mackiewicz J., Rutkowski P.
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
Cancers 2022, 14:2123
DOI:10.3390/cancers14092123
A
6,639
140
26.
Gorka J., Marona P., Kwapisz O., Ryś J., Jura J., Miekus K.
MCPIP1 regulates adhesion kinase and Rho GTPase-dependent migration in clear cell renal cell carcinoma
European Journal of Pharmacology 2022, 922:174804
DOI: 10.1016/j.ejphar.2022.174804
A
4,432
100
27.
Walewski J., Dziurda D., Bidziński M., Bobek-Billewicz B., Dedecjus M., Hus I., Jagielska B., Jassem J., Kawecki A., Kowalski D., Krasztel M., Krzakowski M., Kubiatowski T., Potemski P., Mądry R., Rutkowski P., Rychert A., Ryś J., Składowski K., Tarnawski R., Tchórzewska-Korba H., Tysarowski A., Wysocki P.J., Topór-Mądry R.
Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System
Nowotwory Journal of Oncology2022, 72, 1: 44-50
DOI: 10.5603/NJO.2022.0005
A
100
28.
Evens A.M., Connors J.M., Younes A., Ansell S.M., Kim W.S., Radford J., Feldman T., Tuscano J., Savage K.J.,
Oki Y., Grigg A., PocockCh., Długosz-Danecka M., Fenton K., Forero-Torres A., Liu R., Jolin H., Gautam A., Gallamini A.
Older patients (aged ≥ 60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study
Haematologica 2022, 107(5): 1086-1094
DOI:10.3324/haematol.2021.278438
A
5,935
140
29.
Banas B., Kołodziejczyk P., Czerw A., Banaś T., Kotwas A.
A Retrospective, Single-Centre Study on the Learning Curve for Liver Tumor Open Resection in Patients with Hepatocellular Cancers and Intrahepatic Cholagangiocarcinomas
International Journal of Environmental Research and Public Health 2022, 19, 4872
DOI: 10.3390/ijertph19084872
A
3,390
70
30.
Janecka-Widła A. (Ak), Majchrzyk K., Mucha-Małecka A., Słonina D., Biesaga B.
Prognostic potential of Akt, pAkt(Ser473) and pAkt(Thr308) immunoreactivity in relation to HPV prevalence in head and neck squamous cell carcinoma patients
Pathology-Research and Practice 2022, 229:153684
DOI: 10.1016/j.prp.2021.153684
A
3,250
40
31.
Jabłoński M.J., Garcia-Torres F.,
Zielińska P., Bułat A., Brandys P., Samardakiewicz M.
The usefulness of the QualityMetric Health OutcomesTM Scoring Software 5.0 for predicting the risk of depression in male partners of cancer patients
Oncology in Clinical Practice 2022
Early publication date: 31.05.2022
DOI: 10.5603/OCP..00212022
D
100
32.
Kłek S.
Reply to Lauro, A.;Ripoli, M.C. Comment on “Klek at al. Enhanced Recovery after Surgery (ERAS) Protocol Is a Safe and Effective Approach in Patients with Gastrointestinal Fistulas Undergoing Reconstruction: Results from a Prospective Study. Nutrients 2021, 13, 1953”
Nutrients 2022, 14, 18
DOI: 10.3390/nu14010018
E
5,719
140
33.
Badowska-Kozakiewicz, Fudalej M., Kwaśniewska D., Durlik M., Nasierowska-Guttmajer A., Mormul A., Włoszek E., Czerw A., Banaś T., Deptała A.
Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma – Prevalence, Clinicopathological Variables, and Clinical Outcomes
Cancers 2022, 14: 2840
DOI: 10.3390/cancers14122840
A
6,639
140